Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-039404
Filing Date
2015-06-26
Accepted
2015-06-26 16:34:04
Documents
1
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v414104_4.html 4  
1 OWNERSHIP DOCUMENT v414104_4.xml 4 3954
  Complete submission text file 0001144204-15-039404.txt   5397
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 390 LEXINGTON MA 02421
Business Address
Clarke Robert W. (Reporting) CIK: 0001645327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 15955539